|
CA2665384A1
|
|
Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors
|
|
WO2008150260A1
|
|
8-oxy-2-aminopyrido (2, 3-d) pyrimidin-7-one derivatives as kinase inhibitors and anticancer agents
|
|
EP1914234A1
|
|
Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
|
|
CA2584493A1
|
|
Kinase inhibitors for treating cancers
|
|
CN1922180A
|
|
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
KR20060130624A
|
|
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
WO2004092139A2
|
|
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
CN1798748A
|
|
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
US7230101B1
|
|
Synthesis of methotrexate-containing heterodimeric molecules
|
|
WO03061596A2
|
|
Methods and reagents for generating chimeric serum peptide carri ers
|
|
US6753329B2
|
|
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
WO03047569A1
|
|
Compositions and methods for inhibiting prenyltransferases
|
|
AU2002363253A1
|
|
Endothelial-cell binding peptides for diagnosis and therapy
|
|
EP1832589A1
|
|
Inhibitors of cyclin-dependent kinases,compositions and uses related thereto
|
|
WO03004489A1
|
|
Compositions and methods for inhibiting prenyltransferases
|
|
CA2435277A1
|
|
Chimeric polypeptides of serum albumin and uses related thereto
|
|
WO0246213A2
|
|
Methods and reagents for isolating angiogenic modulators
|
|
IL147714D0
|
|
Chimeric polypeptides of serum albumin and uses related thereto
|
|
AU3526200A
|
|
Generation of conditional yeast mutants, methods and reagents related thereto
|
|
AU3739000A
|
|
Methods and reagents for identifying synthetic genetic elements
|
